Award

Delivery Order #SPE2DP26F2975

Delivery Order for Oxymetazoline Hydro from DMS Pharmaceutical Group

Buyer

Defense Logistics Agency

Award Amount

$6.04

Ceiling

$6.04

Awarded

February 22, 2026

Period of Performance

Feb 22, 2026 – Feb 23, 2026

Identifier

SPE2DP26F2975

NAICS

424210

This award is a delivery order contract, issued under an existing definitive indefinite delivery vehicle (IDV) pharmaceutical supply contract awarded to DMS Pharmaceutical Group Inc. The recipient, DMS Pharmaceutical Group Inc., is a specialized distributor of pharmaceutical products, tasked with supplying critical drug inventories to federal health agencies. The contract specifically procures Oxymetazoline Hydro, a medication used for nasal decongestion, reflecting its importance in maintaining essential pharmaceutical supplies. The scope of work encompasses the timely delivery of this product within a short, clearly defined period of performance in early 2026, ensuring the agency's immediate operational needs are met. This delivery order complements the broader long-term contract that supports continuous availability of various pharmaceuticals. While original procurement was competitively structured under the parent IDV contract, this particular order leverages that framework for efficient fulfillment. The place of performance is located in Park Ridge, Illinois, demonstrating the geographic sourcing of the pharmaceutical supply. Overall, this award plays a significant role in sustaining ongoing public health initiatives by ensuring access to specific vital medications within concise timelines.

Description

8511936315!OXYMETAZOLINE HYDRO

View original record